Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 11:14:1192440.
doi: 10.3389/fimmu.2023.1192440. eCollection 2023.

Pre-transplant immune profile defined by principal component analysis predicts acute rejection after kidney transplantation

Affiliations

Pre-transplant immune profile defined by principal component analysis predicts acute rejection after kidney transplantation

Emilie Gaiffe et al. Front Immunol. .

Abstract

Background: Acute rejection persists as a frequent complication after kidney transplantation. Defining an at-risk immune profile would allow better preventive approaches.

Methods: We performed unsupervised hierarchical clustering analysis on pre-transplant immunological phenotype in 1113 renal transplant recipients from the ORLY-EST cohort.

Results: We identified three immune profiles correlated with clinical phenotypes. A memory immune cluster was defined by memory CD4+T cell expansion and decreased naïve CD4+T cell. An activated immune cluster was characterized by an increase in CD8+T cells and a decreased CD4/CD8 ratio. A naïve immune cluster was mainly defined by increased naïve CD4+T cells. Patients from the memory immune profile tend to be older and to have diabetes whereas those from the activated immune profile were younger and more likely to have pre-transplant exposure to CMV. Patients from the activated immune profile were more prone to experience acute rejection than those from other clusters [(HR=1.69, 95%IC[1.05-2.70], p=0.030) and (HR=1.85; 95%IC[1.16-3.00], p=0.011). In the activated immune profile, those without previous exposure to CMV (24%) were at very high risk of acute rejection (27 vs 16%, HR=1.85; 95%IC[1.04-3.33], p=0.039).

Conclusion: Immune profile determination based on principal component analysis defines clinically different sub-groups and discriminate a population at high-risk of acute rejection.

Keywords: acute rejection; biomarker; hierarchical clustering analysis; immune profile; kidney transplantation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Patient flow chart.
Figure 2
Figure 2
Hierarchical clustering of patients after principal component analysis (A) represented by the dendrogram of patients and (B) by a scatter view plot. (A) identification of 3 clusters among 832 first transplant recipients according to immunological data. Profiles were assigned based on the separation of the clustering trees. (B) Colors were based on clustering profile and mainly defined by dimension 2 and dimension 1 in our hierarchical clustering. Three clusters were identified: older immunity in red (cluster 1), activated immunity in green (cluster 2) and naïve immunity in blue (cluster 3).
Figure 3
Figure 3
Kaplan Meier curves for survival without acute rejection according to cluster belinging. Three clusters were identified: memory immunity in red (cluster 1), activated immunity in green (cluster 2) and naïve immunity in blue (cluster 3).
Figure 4
Figure 4
Competitive risk of death and acute rejection at 1 years post transplantation according to clusters determined with principal component analysis identified as older immunity (cluster 1), activated immunity (cluster 2) and naïve immunity (cluster 3). Three clusters were identified: memory immunity with full line (cluster 1), activated immunity with dashed line (cluster 2) and naïve immunity with dotted line (cluster 3).
Figure 5
Figure 5
Kaplan Meier curves for survival without acute rejection according to patients CMV status of cluster 2 (activated immunity). Patients naïve to CMV exposure were identified with full line and patient exposed to CMV with dashed line.

References

    1. Koo EH, Jang HR, Lee JE, Park JB, Kim SJ, Kim DJ, et al. . The impact of early and late acute rejection on graft survival in renal transplantation. Kidney Res Clin Pract (2015) 34:160–4. doi: 10.1016/j.krcp.2015.06.003 - DOI - PMC - PubMed
    1. Matas AJ, Smith JM, Skeans MA, Thompson B, Gustafson SK, Schnitzler MA, et al. . OPTN/SRTR 2012 annual data report: kidney. Am J Transplant (2014) 14(Suppl 1):11–44. doi: 10.1111/ajt.12579 - DOI - PubMed
    1. Augustine JJ, Siu DS, Clemente MJ, Schulak JA, Heeger PS, Hricik DE. Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. Am J Transplant (2005) 5:1971–5. doi: 10.1111/j.1600-6143.2005.00958.x - DOI - PubMed
    1. Poggio ED, Augustine JJ, Clemente M, Danzig JM, Volokh N, Zand MS, et al. . Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. Transplantation (2007) 83:847–52. doi: 10.1097/01.tp.0000258730.75137.39 - DOI - PubMed
    1. Chen Y, Tai Q, Hong S, Kong S, Shang S, Liang S, et al. . Pretransplantation soluble CD30 level as a predictor of acute rejection in kidney transplantation: a meta-analysis. Transplantation (2012) 94:911–8. doi: 10.1097/TP.0b013e31826784ad - DOI - PubMed

Publication types

MeSH terms